We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+4.66%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$968M
AUM Growth
+$854M
Cap. Flow
+$792M
Cap. Flow %
81.87%
Top 10 Hldgs %
57.56%
Holding
371
New
110
Increased
49
Reduced
126
Closed
30

Sector Composition

Rank Sector Weight
1 Energy 68.15%
2 Healthcare 6.98%
3 Utilities 1.17%
4 Financials 0.09%
5 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXEL icon
76
Exelixis
EXEL
$14.1B
$706K 0.07%
39,851
+2,719
+7% +$53K
VKTX icon
77
Viking Therapeutics
VKTX
$4.04B
$696K 0.07%
39,960
-29,345
-42% -$349K
NI icon
78
NiSource
NI
$22.2B
$680K 0.07%
+27,295
New +$722K
AKCA
79
DELISTED
Akcea Therapeutics Inc
AKCA
$680K 0.07%
19,429
-13,886
-42% -$420K
TVRD
80
Tvardi Therapeutics
TVRD
$24.3M
$676K 0.07%
784
-561
-42% -$405K
MNOV icon
81
MediciNova
MNOV
$64.5M
$675K 0.07%
54,054
-39,714
-42% -$399K
PBYI icon
82
Puma Biotechnology
PBYI
$413M
$652K 0.07%
14,227
+975
+7% +$47K
LXRX icon
83
Lexicon Pharmaceuticals
LXRX
$1.03B
$648K 0.07%
60,728
+4,092
+7% +$46.9K
SJI
84
DELISTED
South Jersey Industries, Inc.
SJI
$645K 0.07%
+18,289
New +$621K
FTEC icon
85
Fidelity MSCI Information Technology Index ETF
FTEC
$19.5B
$643K 0.07%
10,667
-342
-3% -$20K
ACET icon
86
Adicet Bio
ACET
$73.1M
$642K 0.07%
379
-278
-42% -$363K
WEC icon
87
WEC Energy
WEC
$37.4B
$640K 0.07%
+9,591
New +$639K
MRNS
88
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$640K 0.07%
15,992
-11,506
-42% -$327K
RGNX icon
89
Regenxbio
RGNX
$627M
$638K 0.07%
8,452
-6,040
-42% -$435K
XIFR
90
XPLR Infrastructure LP
XIFR
$1.18B
$638K 0.07%
+13,149
New +$624K
MDCO
91
DELISTED
Medicines Co
MDCO
$638K 0.07%
21,335
+1,438
+7% +$54.2K
BCRX icon
92
BioCryst Pharmaceuticals
BCRX
$2.47B
$637K 0.07%
83,470
-59,662
-42% -$401K
AGIO icon
93
Agios Pharmaceuticals
AGIO
$2.25B
$634K 0.07%
8,215
+563
+7% +$45.3K
MYOK
94
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$630K 0.07%
9,666
-6,914
-42% -$407K
CMS icon
95
CMS Energy
CMS
$23B
$628K 0.06%
+12,807
New +$624K
VLP
96
DELISTED
Valero Energy Partners LP
VLP
$628K 0.06%
+16,569
New +$634K
FATE icon
97
Fate Therapeutics
FATE
$281M
$621K 0.06%
38,094
-27,979
-42% -$331K
D icon
98
Dominion Energy
D
$62.1B
$619K 0.06%
+8,811
New +$624K
DVAX
99
DELISTED
Dynavax Technologies
DVAX
$610K 0.06%
49,231
+3,317
+7% +$44.9K
ES icon
100
Eversource Energy
ES
$28.2B
$610K 0.06%
+9,921
New +$607K

Similar funds

Virtus ETF Advisers's Q3 2018 Portfolio in Review

As of Q3 2018, Virtus ETF Advisers held 371 positions worth $968M, up 755% from $113M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Virtus ETF Advisers deployed $792M of net new capital in Q3 2018, opening 110 new positions and adding to 49 existing holdings. Its largest new stake was EQM Midstream Partners, LP: 1,479,454 shares worth $78.1M.

By sector, the portfolio is most concentrated in Energy at 68% of assets, up from 0.33% a quarter earlier, followed by Healthcare and Utilities.

On the sell side, the largest reduction was Vanguard Utilities ETF, an estimated $1.7M trimmed.

  • Virtus ETF Advisers's largest Q3 2018 buy was EQM Midstream Partners, LP: 1,479,454 shares worth $78.1M.
  • Virtus ETF Advisers added most to Marathon Petroleum in Q3 2018, an estimated $60.6M increase.
  • Virtus ETF Advisers's biggest Q3 2018 reduction was Vanguard Utilities ETF, cutting an estimated $1.7M.
  • Virtus ETF Advisers fully exited iShares MSCI India ETF in Q3 2018, selling an estimated $1.24M.
  • Virtus ETF Advisers's ten largest holdings make up 58% of its $968M portfolio in Q3 2018.
  • Virtus ETF Advisers opened 110 new positions and closed 30 in Q3 2018.
  • Virtus ETF Advisers's portfolio value rose 755% quarter-over-quarter to $968M.

Based on Virtus ETF Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.